Apyx Medical Corporation (APYX) vs LENZ Therapeutics, Inc. (LENZ)

A side-by-side comparison of Apyx Medical Corporation and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — APYX vs LENZ

growth of $100 · dividends reinvested · last 5y
APYX -75.4% (-24.5%/yr)LENZ -91.4% (-38.7%/yr)APYX compounded faster over this window
050100150Start $10020222023202420252026$25$9
APYX LENZ

APYX vs LENZ: by the numbers

  • •LENZ is the larger company ($118M vs $109M market cap).
  • •Both run net losses; APYX's is the smaller (-14.78% vs -586.74% net margin).

Metrics side by side

Valuation

MetricAPYXLENZ
P/S ratio1.875.47
P/B ratio10.270.54

Profitability

MetricAPYXLENZ
Gross margin33.94%90.14%
Operating margin-6.06%-477.46%
Net margin-14.78%-586.74%
ROE-80.97%-57.47%
ROIC-6.84%-61.84%

Growth (annualized)

MetricAPYXLENZ
Revenue CAGR (5Y)8.82%N/A
Total return CAGR (5Y)-28.10%-35.49%

Frequently asked

How have APYX and LENZ total returns compared?
Over the past 5 years, APYX delivered -28.10% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.